Treatment Efficacy
12
1
2
6
Key Insights
Highlights
Success Rate
86% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
8.3%
1 terminated out of 12 trials
85.7%
-0.8% vs benchmark
17%
2 trials in Phase 3/4
17%
1 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (12)
Eribulin Mesylate-based Therapy in Patients With Advanced HER2-negative Breast Cancer Previously Treated With ADC
Predicting Treatment Outcomes in Refractory Constipation Through Brain Connectivity Evaluation
Effects of Eccentric Banded Leg Curls Versus Eccentric Cable Leg Curls Exercises in Cricket Players
A ReaL World Study of DS-8201
Combination of HX008 And Niraparib in GErm-line-mutAted Metastatic Breast Cancer
Efficacy and Safety of Continuous Versus Intermittent Linezolid Infusion in Critically Ill Patients With Septic Shock
TCR Modified T Cells MDG1011 in High Risk Myeloid and Lymphoid Neoplasms
Lubiprostone for Functional Constipation in the Under 18 Years Patients
Randomized-controlled Trial of the Effectiveness of COVID-19 Early Treatment in Community
Peanut Oral Immunotherapy in Children: IMPACT Follow Up Study
Early Simplified: A Trial to Compare the Efficacy of Standard of Care Combination Antiretroviral Therapy With a Simplified Dolutegravir Monotherapy in Patients With a Primary HIV-1 Infection
A Pilot Study of MONOtherapy of DOlutegravir in HIV-1 Virologically Suppressed Patients